← Back to patent-cliff list
CAS 27806-88-8
Methyl N-(2,6-dichlorophenyl)carbamimidothioate hydrogen iodide
Codes：(III)122568-1-a
Application context (from source-drug indications)
注意力缺陷障碍伴多动盐酸可乐定 (Tris Pharma)高血压盐酸可乐定 (Tris Pharma)
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 盐酸可乐定 (Tris Pharma)Clonidine Hydrochloride (Tris Pharma) | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,6-Dichloroaniline→(2,6-dichlorophenyl)thiourea→N-[(2,6-Dichlorophenyl)carbamothioyl]benzamide→Methyl N-(2,6-dichlorophenyl)carbamimidothioate hydrogen iodide→1,2-Diaminoethane
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.